YAP1 and cancer: In cancers, aberrant activation of YAP1 has been reported by divergent signaling and pathways such as mechanical forces, PI3K, and G protein‐coupled receptor signaling (Yu et al., 2014; Yu et al., 2012a; Yu et al., 2012b).